Cascade Pharma

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of nuclear receptor drugs intended to provide new therapies for chronic liver diseases. Cascade Pharma is based in Shanghai, China and was founded in 2017. It has raised $218 million.

Last price · $/share
—
Implied valuation
—
Total raised
$217.6M
Last round
—

Who backs Cascade Pharma?

24 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cascade Pharma investors

24 investors are on record for Cascade Pharma, including Puhua Capital, Lapam Capital, CAS Investment Management and Shanghai Pudong Venture Capital.

Free account
More of Cascade Pharma with a free account
  • ·The complete investor list: 24 names
  • ·Watch Cascade Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Cascade Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View